Assura (AGR)
market vs.
industry GROWTH & VALUE
| 12m Forecast Rolling | ||||
| PE Ratio (f) | 17.6 |
|
|
|
| PEG Ratio (f) |
|
|
||
| EPS Growth (f) | % |
|
|
|
| Dividend Yield (f) | % |
|
|
|
| Valuation (ttm) | ||||
| Price to Book Value | 0.95 |
|
|
|
| Price to Tang. Book |
|
|
||
| Price to Free Cashflow |
|
|
||
| Price to Sales |
|
|
||
| EV to EBITDA |
|
|
||
market vs.
industry QUALITY
| Year End 31st Mar | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014E | 2015E | CAGR / Avg | |
| Revenue | £m | |||||||||
| Operating Profit | £m | |||||||||
| Net Profit | £m | |||||||||
| EPS Reported | p | |||||||||
| EPS Normalised | p | |||||||||
| EPS Growth | % | |||||||||
| PE Ratio | x | |||||||||
| PEG | x | |||||||||
| Profitability | ||||||||||
| Operating Margin | % | |||||||||
| ROA | % | |||||||||
| ROCE | % | |||||||||
| ROE | % | |||||||||
| Cashflow | ||||||||||
| Op. Cashflow ps | p | |||||||||
| Capex ps | p | |||||||||
| Free Cashflow ps | p | |||||||||
| Last ex-div: 10th Jul, paid: 24th Jul more... Dividends | ||||||||||
| Dividend ps | p | |||||||||
| Dividend Growth | % | |||||||||
| Dividend Yield | % | |||||||||
| Dividend Cover | x | |||||||||
| Balance Sheet | ||||||||||
| Cash etc | £m | |||||||||
| Working Capital | £m | |||||||||
| Net Fixed Assets | £m | |||||||||
| Net Debt | £m | |||||||||
| Book Value | £m | |||||||||
| Average Shares | m | |||||||||
| Book Value ps | p | -19.4% | ||||||||
FINANCIAL BRIEF: For the fiscal year ended 31 March 2013, Assura Group Limited revenues increased 9% to L37.1M. Net income before extraordinary items totaled L14.1M vs. loss of L62.3M. Revenues reflect Rent Receivable increase of 2% to L34M, Other fees receivable increase of 14% to L800K. Net Income reflects Unreal loss on revalue of derivatives decrease of 98% to L1.2M (expense), Impairment of goodwill decrease from L20M (expense) to L0K. more »
| Leverage (ttm) | Total | Ex Intang | |||
| Gross Gearing | % | ||||
| Net Gearing | % | ||||
| Cash / Assets | % | ||||
| Liquidity (ttm) | ||
| Current Ratio | ||
| Quick Ratio | ||
| Interest Cover | ||
| Efficiency (ttm) | ||
| Asset Turnover | ||
| Rec's Turnover | ||
| Stock Turnover | ||
market vs.
industry RECENT HISTORY
| Latest interim period (ended 31st Mar '13) vs. prior year | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| 3yr Average Annualised | ||||
| Sales Growth | % |
|
|
|
| EPS Growth | % |
|
|
|
| DPS Growth | % |
|
|
|
BROKER CONSENSUS & FORECAST TREND
| Recommendation: | Strong Sell | Sell | Hold | Buy | Strong Buy |
|---|---|---|---|---|---|
| No. of Analysts: | 0 | 0 | 1 | 2 | 0 |
Assura Group Limited (Assura Group) is a closed-ended investment company. Its objective to achieve capital growth and rising rental income from the ownership and development of a diversified portfolio of primary health care properties. It operates in three segments: the Core segment, LIFT and the non-core segment. The Core segment invests in, manages and develops primary care premises. LIFT companies develop and invest in medical centers in partnership between the public and private sectors. All these companies are associated companies which have financial investments in the LIFT companies. The non-core segment manages the assets to realize maximum value through both income and capital receipts from sales. It is a specialist healthcare property partner that works with GPs, health professionals and the NHS. During the fiscal year ended March 31, 2012, the Pharmacy and LIFT Consultancy businesses were sold. In January 2013, it sold its former Head Office building in Daresbury, Cheshire.
Directors: Simon Laffin (CEO) 54, Graham Roberts (Fin. Dir.) 40, Jonathan Murphy (Secy.) ,
No. of Employees: 25 No. of Shareholders: n/a
| Last Annual | March 31st, 2013 |
| Last Interim | March 31st, 2013 |
| Shares in Issue | 525,330,705 |
| Free Float | 345.3m (65.7%) |
| Sector | Healthcare |
| Industry | Healthcare Providers & Services |
| Index | |
| Exchange |
London Stock Exchange (Full) |
| Eligible for | an ISA? a SIPP? |
| Address | , WARRINGTON, WA4 6HL, United Kingdom |
| Web | http://assuragroup.co.uk |
| Phone | +44 1925 420660 |
| Contact | Serena Tremlett (Secy.) |
| Auditors | Deloitte LLP |
| 28th May | Unaudited Preliminary Results to 31 March 2013 |
| 28th May | Rejection of MedicX Proposal |
| 2nd Apr | Confirmation of REIT status |
| 13th Mar | Director/PDMR Shareholding |
| 15th Feb | Results of EGM |
| 31st Jan | Interim Management Statement |
Recent ↓
